Matthew Paul, MD
Ophthalmology · Danbury, CTNPI 1417955865
Payments from drug & device makers
Across 285 payments — averaging $3311.51 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$601K
- Bausch Health US, LLC$163K
- Genentech, Inc.$53K
- Shire North American Group Inc$41K
- Oyster Point Pharma, Inc.$22K
- Perrigo Company PLC$19K
- plus $45K from 17 others
Across 15 payments — averaging $183.10 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- AbbVie$3K
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 163 | $600,627 |
| Bausch Health US, LLC | 23 | $162,740 |
| Genentech, Inc. | 14 | $53,360 |
| Shire North American Group Inc | 5 | $41,036 |
| Oyster Point Pharma, Inc. | 12 | $22,005 |
| Perrigo Company PLC | 2 | $18,989 |
| Osmotica Pharmaceutical Corp. | 6 | $15,623 |
| Sun Pharmaceutical Industries Inc. | 7 | $10,684 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $8,637 |
| Johnson & Johnson Surgical Vision, Inc. | 9 | $2,774 |
| Apellis Pharmaceuticals, Inc. | 4 | $2,539 |
| Eyepoint US, Inc. | 6 | $2,163 |
| Carl Zeiss Meditec USA, Inc. | 3 | $1,405 |
| Bausch & Lomb Americas Inc. | 9 | $501 |
| Alcon | 8 | $265 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 4 | $196 |
| Rxsight Inc | 2 | $90 |
| Tarsus Pharmaceuticals, Inc. | 2 | $39 |
| Lombart Brothers, Inc. | 1 | $29 |
| Rayner Intraocular Lenses Limited | 1 | $28 |
| Aerie Pharmaceuticals, Inc. | 1 | $23 |
| Amgen | 1 | $16 |
| ABB Con-cise Optical Group LLC | 1 | $12 |
How this compares
$943,779 in reported general payments places this provider in the 95th percentile of 279 ophthalmology providers in Connecticut.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other ophthalmology in Danbury
- Mary TamDanbury$5K
- Amir CohenNew Haven$441K
- John HuangHartford$390K
- James MurphyHamden$176K
- Anthony DanielsNew Haven$66K
- James TalbotNew Canaan$47K
- Paul KangNew Haven$40K
- Anish ShahNorwich$38K
- Alan SolinskyWest Hartford$35K
- Michael KovalFarmington$35K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.